NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/12/2026
Back to search
Official data from USPTO
AUBURN PHARMACEUTICAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
AUBURN PHARMACEUTICAL
ST13
US500000088402294Class
35
Filing
88402294
Registration
6279874
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
06/13/2026
Trademark type
Word
Nice classes
35
Filing date
04/25/2019
Registration date
03/02/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/12/2026
Last transaction
06/13/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
1993-07-00
First use in commerce
1993-07-00
Drawing code
4
Owner type
16
Owner location
ROCHESTER HILLS, MI, US
Examiner
KHOURI, SANI PHILIPPE
Current location
Historical data usage
Holders and representatives
Holders
AUBURN PHARMACEUTICAL, LLC
Auburn Pharmaceutical Company
Auburn Pharmaceutical Company
Representatives
Robyn S. Lederman Brooks Kushman P.C.
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
On-line wholesale store services featuring pharmaceuticals; Wholesale services by direct solicitation by sales agents in the field of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
40 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/12/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/12/2026
E815
TEAS SECTION 8 & 15 RECEIVED
03/17/2026
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/02/2026
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
12/04/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/11/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/11/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/11/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/11/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/11/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
03/02/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/15/2020
PUBO
PUBLISHED FOR OPPOSITION
12/15/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/25/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/09/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/22/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/21/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
10/21/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/14/2020
GNFR
FINAL REFUSAL E-MAILED
09/14/2020
CNFR
FINAL REFUSAL WRITTEN
09/14/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/22/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/21/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/21/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/23/2020
GNRT
NON-FINAL ACTION E-MAILED
02/23/2020
CNRT
NON-FINAL ACTION WRITTEN
02/23/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
08/03/2019
GNSL
LETTER OF SUSPENSION E-MAILED
08/03/2019
CNSL
SUSPENSION LETTER WRITTEN
08/03/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/24/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/23/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/23/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/13/2019
GNRT
NON-FINAL ACTION E-MAILED
07/13/2019
CNRT
NON-FINAL ACTION WRITTEN
07/13/2019
DOCK
ASSIGNED TO EXAMINER
07/08/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/11/2019
NWAP
NEW APPLICATION ENTERED
04/29/2019
Continuous trademark protection
Get notified about every new filing that threatens AUBURN PHARMACEUTICAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.